Andrographolide inhibits the proliferation and migration of vascular smooth muscle cells via PI3K/AKT signaling pathway and amino acid metabolism to prevent intimal hyperplasia
- 30 September 2023
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 959, 176082
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82204659)
This publication has 65 references indexed in Scilit:
- Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosisCardiovascular Research, 2014
- Andrographolide Suppresses IL-6/Stat3 Signaling in Peripheral Blood Mononuclear Cells from Patients with Chronic Rhinosinusitis with Nasal PolypsInflammation, 2014
- Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancerClinical and Experimental Pharmacology and Physiology, 2012
- Inhibition of TNF-α-Induced Inflammation by Andrographolide via Down-Regulation of the PI3K/Akt Signaling PathwayJournal of Natural Products, 2011
- Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 inductionCardiovascular Research, 2011
- Andrographolide Enhances Nuclear Factor-κB Subunit p65 Ser536 Dephosphorylation through Activation of Protein Phosphatase 2A in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2011
- Recent advances in arginine metabolism: roles and regulation of the arginasesBritish Journal of Pharmacology, 2009
- Arginine metabolism in vascular biology and diseaseVascular Medicine, 2005
- Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathwayBiochemical Pharmacology, 2004
- Rapamycin inhibits vascular smooth muscle cell migration.Journal of Clinical Investigation, 1996